Sodium chloride 0.9% Glucose 5% infusion 1litre Viaflex bags

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Sodium chloride; Glucose

Disponibbli minn:

Baxter Healthcare Ltd

Kodiċi ATC:

B05BB01

INN (Isem Internazzjonali):

Sodium chloride; Glucose

Dożaġġ:

9mg/1ml ; 50mg/1ml

Għamla farmaċewtika:

Infusion

Rotta amministrattiva:

Intravenous

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 09020201

Karatteristiċi tal-prodott

OBJECT 1
SODIUM CHLORIDE 0.9 % W/V AND GLUCOSE 5% W/V
SOLUTION FOR INFUSION BP
Summary of Product Characteristics Updated 01-Jun-2016 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP
2. Qualitative and quantitative composition
Sodium Chloride:
Glucose (as monohydrate):
9.0 g/l (0.9% w/v)
50.0 g/l (5.0% w/v)
Each ml contains 50 mg glucose (as monohydrate) and 9.0 mg sodium
chloride.
Mmol/l:
Meq/l:
Na
+
: 154
Na
+
: 154
Cl
-
:154
Cl
-
:154
Nutritional value: approximately 840 kJ/l (or 200 kcal/l)
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles.
Osmolarity: 585 mosm/l (approx)
pH: 3.5 to 6.5
4. Clinical particulars
4.1 Therapeutic indications
Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution is indicated
for:
- Treatment of sodium depletion, extracellular dehydration or
hypovolaemia in cases where supply of
water and carbohydrates is required due to restriction of the intake
of fluids and electrolytes by normal
routes.
4.2 Posology and method of administration
The choice of the specific sodium chloride and glucose concentration,
dosage, volume, rate and duration
of administration depends on the age, weight, clinical condition of
the patient and concomitant therapy. It
should be determined by a physician. For patients with electrolyte and
glucose abnormalities and for
paediatric patients, consult a physician experienced in intravenous
fluid therapy. Rapid correction of
hyponatraemia and hypernatraemia is potentially dangerous (risk of
serious neurologic complications).
_ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER):_
The recommended dosage is: 500 ml to 3 L/24h
Administration rate:
The infusion rate is usually 40 ml/kg/24h and should not exceed the
patient's glucose oxidation capacities
in order to avoid hyperglycaemia. Therefore the maximum acute
administration rate is 5 mg/kg/min.
_PAEDIATRIC POPULATION_
The dosage varies with